Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-21

Clinical Trial Update: Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder [NA]

View source ↗

Summary

Open-label trial of quetiapine (Seroquel) for treatment-resistant functional bowel disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Functional Bowel Disorders | NA | Status: COMPLETED | Results posted: 2014-03-21